# Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)

> **NCT00262054** · PHASE4 · COMPLETED · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 4570 (actual)

## Conditions studied

- Coronary Disease
- Angina Pectoris

## Interventions

- **DRUG:** Bivalirudin
- **DRUG:** Un-fractionated heparin

## Key facts

- **NCT ID:** NCT00262054
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2008-02
- **Final completion:** 2008-05
- **Target enrollment:** 4570 (ACTUAL)
- **Last updated:** 2010-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00262054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00262054, "Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00262054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*